首页 文献索引 SCI期刊 AI助手
登录 注册
期刊目录筛选

期刊名:Clinical colorectal cancer

缩写:CLIN COLORECTAL CANC

ISSN:1533-0028

e-ISSN:1938-0674

IF/分区:3.3/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1037
Jane McKenzie,Vanessa Wong,Shehara Mendis et al. Jane McKenzie et al.
Background: Epidermal growth factor receptor inhibitors (EGFRi), most commonly cetuximab and panitumumab, are first-line options for patients with left-sided, RAS wildtype (RASwt) metastatic colorectal cancer. Limited dat...
Peter Gibbs,Khalid Abubaker,Danyi Wang et al. Peter Gibbs et al.
Introduction: Colorectal cancer (CRC), a global health concern, requires effective treatments. Anti-epidermal growth factor receptor (anti-EGFR) monoclonal antibodies are used for RAS wild-type and BRAFV600 mutation-negat...
Seong-Eun Kim,Ji Sung Lee,Sun Young Kim et al. Seong-Eun Kim et al.
Background: RAS mutations are important biomarkers for predicting the efficacy of anti-EGFR treatment in metastatic colorectal cancer (mCRC). The emergence of RAS mutations is a known resistance mechanism. This study aime...
Caroline L Kahn,Mathias M Petersen,Jakob Kleif et al. Caroline L Kahn et al.
Background: Early detection is paramount when reducing incidence and mortality of colorectal cancer (CRC). Current population-based screening programs primarily use fecal immunochemical test (FIT) to allocate individuals ...
Andrew C Gordon,Saad Abu Zahra,Muhamad Serhal et al. Andrew C Gordon et al.
Purpose: This study evaluates the safety and efficacy of escalated-dosing Yttrium-90 transarterial radioembolization (TARE) for unresectable, unablatable metastatic colorectal cancer (mCRC) to the liver. ...
Hyunwook Kim,Lingjie Shen,Jeongseok Jeon et al. Hyunwook Kim et al.
Background: Lymph node (LN) examination is important for staging colorectal cancer. Examining < 12 LN has been associated with a poor prognosis. However, surgical and pathological advances have led to increase examined LN...
Kim van den Berg,Felice N van Erning,Jacobus Wa Burger et al. Kim van den Berg et al.
Background: A 3-month adjuvant treatment regimen with capecitabine and oxaliplatin (CAPOX) for high-risk stage II (T4N0) and stage III (node-positive) colon cancer was implemented in the Netherlands in 2017. The IDEA tria...
Andrea Cercek,Jean-Baptiste Bachet,Jaume Capdevila et al. Andrea Cercek et al.
Background: Colorectal cancer (CRC) had the second highest cancer mortality worldwide in 2020; nearly a third of CRCs were rectal cancers (RC). A recent study demonstrated that dostarlimab, an immune-checkpoint inhibitor,...
Neal Bhutiani,Mahmoud Mg Yousef,Abdelrahman Mg Yousef et al. Neal Bhutiani et al.
Introduction: Extramural vascular invasion (EMVI) is associated with distant recurrence after treatment of locogionally advanced rectal adenocarcinomas (LARCs), but its use as a marker for response to neoadjuvant therapy ...